Select Equity Group L.P. decreased its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 30.0% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,097,728 shares of the medical instruments supplier’s stock after selling 470,804 shares during the quarter. Select Equity Group L.P. owned 0.49% of DENTSPLY SIRONA worth $48,048,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Veritas Asset Management LLP raised its position in shares of DENTSPLY SIRONA by 19.9% during the second quarter. Veritas Asset Management LLP now owns 10,092,601 shares of the medical instruments supplier’s stock valued at $441,753,000 after buying an additional 1,674,946 shares during the last quarter. Nuance Investments LLC raised its position in shares of DENTSPLY SIRONA by 134.6% during the second quarter. Nuance Investments LLC now owns 2,174,311 shares of the medical instruments supplier’s stock valued at $95,170,000 after buying an additional 1,247,670 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its position in shares of DENTSPLY SIRONA by 43.1% during the second quarter. Thompson Siegel & Walmsley LLC now owns 2,213,839 shares of the medical instruments supplier’s stock valued at $96,899,000 after buying an additional 667,148 shares during the last quarter. Bank of America Corp DE raised its position in shares of DENTSPLY SIRONA by 18.2% during the second quarter. Bank of America Corp DE now owns 3,112,821 shares of the medical instruments supplier’s stock valued at $136,248,000 after buying an additional 479,365 shares during the last quarter. Finally, Mawer Investment Management Ltd. raised its position in shares of DENTSPLY SIRONA by 185.6% during the second quarter. Mawer Investment Management Ltd. now owns 734,943 shares of the medical instruments supplier’s stock valued at $32,168,000 after buying an additional 477,626 shares during the last quarter. 97.65% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently issued reports on XRAY. BidaskClub upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, July 6th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Wednesday, June 6th. Barclays reduced their price objective on shares of DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 8th. HC Wainwright set a $40.00 price objective on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Friday, August 31st. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $54.00 to $40.00 in a research report on Wednesday, August 8th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $52.18.

Shares of XRAY opened at $38.79 on Friday. DENTSPLY SIRONA Inc has a fifty-two week low of $37.46 and a fifty-two week high of $68.98. The firm has a market capitalization of $8.62 billion, a P/E ratio of 14.58, a price-to-earnings-growth ratio of 2.24 and a beta of 1.20. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. The company had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the previous year, the business posted $0.65 earnings per share. analysts anticipate that DENTSPLY SIRONA Inc will post 2.08 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 12th. Investors of record on Friday, September 28th will be given a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Thursday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is presently 13.16%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: Book Value Of Equity Per Share – BVPS Explained

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.